3860611000001100: Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\UK product\Virtual medicinal product\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\UK product\Virtual therapeutic moiety\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\UK product\Trade family\Graneodin\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)

\Medicinal product\Medicinal product categorized by disposition\Product containing gramicidin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\Medicinal product\Medicinal product categorized by disposition\Product containing neomycin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing peptide\Product containing gramicidin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\Medicinal product\Medicinal product categorized by structure\Product containing glycoside\Product containing aminoglycoside\Medicinal product containing aminoglycoside and acting as antibacterial agent (product)\Product containing neomycin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing aminoglycoside and acting as antibacterial agent (product)\Product containing neomycin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Product containing gramicidin\Product containing gramicidin and neomycin\Neomycin + Gramicidin\Neomycin 0.25% / Gramicidin 0.025% ointment\Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17930701000001115 Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

38295601000001117 Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Is a	Neomycin 0.25% / Gramicidin 0.025% ointment	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has active ingredient	Neomycin sulfate	false	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has active ingredient	Gramicidin	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has manufactured dose form	Ointment	false	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Is a	Graneodin	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Neomycin	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has specific active ingredient	Neomycin sulfate	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has specific active ingredient	Gramicidin	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has active ingredient	Neomycin	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has dispensed dose form	Ointment	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has manufactured dose form	Ointment	false	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Has basis of strength substance	Neomycin	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram	Is pack of	False	Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Inferred relationship	Existential restriction modifier
Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 25 gram	Has AMP	True	Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17930701000001115	Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Limited) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
38295601000001117	Graneodin ointment (Bristol-Myers Squibb Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module